Strategy for Immunogen Design CCR 5 Utilization and Suggests a New Identifies Differences in Glycosylation and C Human Immunodeficiency Virus Type 1 Acute and Chronic Infections with Subtype Comparison of Viral Env Proteins from

Published Ahead of Print 24 April 2013. 2013, 87(13):7218. DOI: 10.1128/JVI.03577-12. J. Virol. Carolyn Williamson and Ronald Swanstrom Beatrice H. Hahn, Myron S. Cohen, David Montefiori, Karim, Barton F. Haynes, George M. Shaw, Bette T. Korber, Vermeulen, Susan Fiscus, Lynn Morris, Salim Abdool Tang, Celia Labranche, Benhur Lee, Andrew Saville, Marion Ngandu, Cathal Seoighe, Irving Hoffman, Feng Gao, Yuyang Jabara, Jennifer Kirchherr, Clement Mapanje, Nobubelo Penny Moore, Maria G. Salazar, Shilpa Iyer, Cassandra Ming Zhang, Jessica Keys, E. Lake Potter, Haitao Chu, P. Kincer, Florette K. Treurnicht, Leslie Arney, Suany Ojeda, Melissa-Rose Abrahams, Jesus F. Salazar-Gonzalez, Laura Li-Hua Ping, Sarah B. Joseph, Jeffrey A. Anderson, Strategy for Immunogen Design CCR5 Utilization and Suggests a New Identifies Differences in Glycosylation and C Human Immunodeficiency Virus Type 1 Acute and Chronic Infections with Subtype Comparison of Viral Env Proteins from